| 1.1 | Approve Financial Statements | Abstain |
| 1.2 | Approve the Remuneration Report | Abstain |
| 2 | Approve Allocation of Income and Dividends of CHF 2.60 per Share | For |
| 3 | Approve Discharge of Board and Senior Management | Oppose |
| 4.1 | Approve Remuneration of Board of Directors in the Amount of CHF 3.8 Million from 2022 AGM Until 2023 AGM | For |
| 4.2.1 | Approve Variable Cash-Based Remuneration of Executive Committee in the Amount of CHF 13.2 Million for Fiscal Year 2021 | Abstain |
| 4.2.2 | Approve Variable Share-Based Remuneration of Executive Committee in the Amount of CHF 13.2 Million for Fiscal Year 2022 | Oppose |
| 4.2.3 | Approve Fixed Remuneration of Executive Committee in the Amount of CHF 9.2 Million for Fiscal Year 2023 | For |
| 5.1.1 | Re-elect Romeo Lacher - Chair (Non Executive) | Abstain |
| 5.1.2 | Re-elect Gilbert Achermann - Non-Executive Director | For |
| 5.1.3 | Re-elect Heinrich Baumann - Non-Executive Director | Oppose |
| 5.1.4 | Re-elect Richard Campbell-Breeden - Non-Executive Director | For |
| 5.1.5 | Re-elect Ivo Furrer - Non-Executive Director | For |
| 5.1.6 | Re-elect David Nicol - Non-Executive Director | For |
| 5.1.7 | Re-elect Kathryn Shih - Non-Executive Director | For |
| 5.1.8 | Re-elect Eunice Zehnder-Lai - Non-Executive Director | For |
| 5.1.9 | Re-elect Olga Zoutendijk - Non-Executive Director | For |
| 5.2 | Elect Tomas Varela Muiña - Non-Executive Director | For |
| 5.3 | Re-elect Romeo Lacher as Board Chair | Abstain |
| 5.4.1 | Elect Remuneration Committee member: Gilbert Achermann | Oppose |
| 5.4.2 | Elect Remuneration Committee member: Richard Campbell-Breeden | For |
| 5.4.3 | Elect Remuneration Committee member: Kathryn Shih | For |
| 5.4.4 | Elect Remuneration Committee member: Eunice Zehnder-Lai | For |
| 6 | Ratify KPMG AG as Auditors | Oppose |
| 7 | Designate Marc Nater as Independent Proxy | For |
| 8 | Approve CHF 148,464 Reduction in Share Capital as Part of the Share Buyback Program via Cancellation of Repurchased Shares | For |
| 9 | Transact Any Other Business | Oppose |
